跳至主要内容
临床试验/CTRI/2025/01/079508
CTRI/2025/01/079508
尚未招募
不适用

T o evaluate and compare the in vivo efficacy (12 hr. moisturization time claim) and safety of Skin Care Formulation verses Untreated Control in terms of skin moisturization on healthy female subjects

Panacea Biotec Pharma Ltd.1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2025年2月4日最近更新:

概览

阶段
不适用
状态
尚未招募
发起方
Panacea Biotec Pharma Ltd.
入组人数
33
试验地点
1
主要终点
skin

概览

简要总结

OBJECTIVE

The objective of this study will be to evaluate and compare the in vivo efficacy and safety of Skin Care Formulation verses Untreated Control in terms of skin moisturization on healthy female subjects for product.

Test Product: Baby Massage Oil: Product A

Baby Lotion: Product B

Techniques: The evaluation is performed using: 1) Subject Self Evaluation, 2) Dermatological Evaluation: Safety and 3) Corneometry

Total duration of the study: 12 hours following the first application of the product.

Kinetics: T0, T+30 Minutes after product application, T+6 Hours after product application, T+8 Hours after product application & T+12 Hours after product application

POPULATION: 33 female subjects will be selected for the study.

The subjects selected for this study are healthy female subject, aged between 18 and 40 years old, having dry skin on forearms

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Indian female subjects 2)Healthy subjects 3) Skin is healthy on the studied anatomic unit 4) Subject having dry skin on forearms.

排除标准

  • Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • Having refused to give her assent by not signing the consent form and Informed consent form
  • Taking part in another study liable to interfere with this study
  • Being known diabetic case
  • Known asthma case
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
  • Being known thyroid case
  • Being epileptic.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
  • Known case of hypersensitivity.

结局指标

主要结局

skin

时间窗: T0, 30 Minutes | after product application, 6 Hours after product application, 8 Hours after product application | & 12 Hours after product application

moisturization

时间窗: T0, 30 Minutes | after product application, 6 Hours after product application, 8 Hours after product application | & 12 Hours after product application

次要结局

未报告次要终点

研究者

发起方
Panacea Biotec Pharma Ltd.
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Pooja Yadav

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验